» Authors » Stephen K Hunter

Stephen K Hunter

Explore the profile of Stephen K Hunter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 274
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mhyre J, DOria R, Hameed A, Lappen J, Holley S, Hunter S, et al.
Obstet Gynecol . 2014 Sep; 124(4):782-786. PMID: 25198266
Case reviews of maternal death have revealed a concerning pattern of delay in recognition of hemorrhage, hypertensive crisis, sepsis, venous thromboembolism, and heart failure. Early-warning systems have been proposed to...
12.
Santillan M, Santillan D, Scroggins S, Min J, Sandgren J, Pearson N, et al.
Hypertension . 2014 Jul; 64(4):852-9. PMID: 25001273
Preeclampsia, a cardiovascular disorder of late pregnancy, is characterized as a low-renin hypertensive state relative to normotensive pregnancy. Because other nonpregnant low-renin hypertensive disorders often exhibit and are occasionally dependent...
13.
Santillan M, Leslie K, Hamilton W, Boese B, Ahuja M, Hunter S, et al.
Eur J Obstet Gynecol Reprod Biol . 2014 Jun; 179:94-9. PMID: 24965987
Objective: The objective is to develop a biorepository of samples that represent all stages of a women's life. Importantly, our goal is to collect longitudinal physical specimens as well as...
14.
Kyser K, Lu X, Santillan D, Santillan M, Hunter S, Cahill A, et al.
Am J Obstet Gynecol . 2012 Jun; 207(1):42.e1-17. PMID: 22727347
Objective: The purpose of this study was to examine the relationship between delivery volume and maternal complications. Study Design: We used administrative data to identify women who had been admitted...
15.
Santillan D, Rai K, Santillan M, Krishnamachari Y, Salem A, Hunter S
Am J Obstet Gynecol . 2011 Aug; 205(3):249.e1-8. PMID: 21802065
Objective: The purpose was to examine in mice the efficacy of various polymeric-encapsulated C5a peptidase vaccine formulations in eliciting a long-term immune response and preventing group B streptococcus (GBS) infection....
16.
Santillan M, Santillan D, Sigmund C, Hunter S
Drug News Perspect . 2010 Jan; 22(9):531-41. PMID: 20072730
In the United States, preeclampsia (PreE) affects 5-7% of all pregnancies, yet represents 15% of all maternal-fetal morbidity and mortality. PreE causes fetal growth restriction, oligohydramnios, fetal death, and maternal...
17.
Santillan D, Santillan M, Hunter S
Am J Obstet Gynecol . 2009 Jul; 201(3):289.e1-6. PMID: 19631922
Objective: The objective of this work was to determine whether cells overexpressing phenylalanine (Phe) hydroxylase (PAH) can significantly reduce Phe in vitro for potential use as a therapy for preventing...
18.
Santillan D, Andracki M, Hunter S
Am J Obstet Gynecol . 2007 Oct; 198(1):114.e1-6. PMID: 17905172
Objective: The purpose of the study was to test whether C5a peptidase encapsulated within a biodegradable polymer can act as a vaccine and elicit an immune response to prevent group...
19.
Tilakaratne H, Yang B, Hunter S, Andracki M, Rodgers V
Artif Organs . 2007 Jun; 31(7):521-31. PMID: 17584476
The feasibility of myoglobin (Mb)-facilitated oxygen transport in improving porcine islet survival under hypoxia was investigated. Discrete groups of islets were transfected with replication-defective adenoviral vector Ad5 respiratory syncitial virus...
20.
Tilakaratne H, Hunter S, Andracki M, Benda J, Rodgers V
Biomaterials . 2006 Sep; 28(1):89-98. PMID: 16952396
Multi-protein (10-250 kDa) endothelial cell growth supplement (ECGS) contains growth factors of varying sizes resulting in advanced release rates from diffusion-based drug delivery devices. As a result, the biochemical stimulus...